Middle East Respiratory Syndrome Outbreak in Korea, 2015.
10.14776/piv.2015.22.3.131
- Author:
Eun Hwa CHOI
1
Author Information
1. Department of Pediatrics, Seoul National University College of Medicine, Seoul, Republic of Korea. eunchoi@snu.ac.kr
- Publication Type:Review
- Keywords:
Middle East Respiratory Syndrome;
coronavirus;
epidemiology
- MeSH:
Bahrain;
China;
Chronic Disease;
Contact Tracing;
Coronavirus;
Delivery of Health Care;
Emergency Service, Hospital;
Epidemiology;
Health Facilities;
Humans;
Korea*;
Male;
Middle East*;
Public Health;
Qatar;
Quarantine;
Saudi Arabia;
United Arab Emirates
- From:Pediatric Infection & Vaccine
2015;22(3):131-135
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Since April 2012, more than 1,600 laboratory-confirmed human infections with Middle East Respiratory Syndrome Coronavirus (MERS-CoV) have been reported, occurring primarily in countries in the Arabian Peninsula; the majority in Saudi Arabia. The MERS outbreak in Korea, which began in May 2015 through the importation of a single case who had recently traveled to Bahrain, the United Arab Emirates, Saudi Arabia, and Qatar. As of November 28th, 186 secondary and tertiary cases had been reported; 38 deaths, mainly associated with underlying chronic illnesses, were reported. One case was exported to China and has been recorded as the first MERS case in China. Thirty-seven confirmed cases were associated with the index case, who was hospitalized from May 15 to May 17. Emergency room at one of the nation's largest hospitals had been affected by hospital-to-hospital and intra-hospital transmissions of MERS-CoV, resulting in an outbreak of 90 infected patients. The vast majority of 186 confirmed cases are linked to a single transmission chain associated with health facilities. The median age of patients is 55 years, with a range of 16 to 87 years. The majority (61%) of patients are men. Twenty-five (14%) of the cases involve healthcare workers. The overall median incubation period was six days, but it was four days for secondary cases and six days for tertiary cases. There has been no evidence of airborne transmission and sustained human-to-human transmission in communities. Intensified public health measures, including contact tracing, quarantine and isolation of all contacts and suspected cases, and infection prevention and control have brought the MERSCoV under control in Korea. Since 4 July no new cases have been reported.
